Literature DB >> 21607685

Negative correlation between aqueous vascular endothelial growth factor levels and axial length.

Osamu Sawada1, Taichiro Miyake2, Masashi Kakinoki2, Tomoko Sawada2, Hajime Kawamura2, Masahito Ohji2.   

Abstract

PURPOSE: The aim of this study was to evaluate the relationship between the concentrations of vascular endothelial growth factor (VEGF) in the aqueous humor and axial length.
METHODS: Aqueous humor samples were obtained from 60 eyes of 60 patients without ocular diseases other than cataracts. No patients with diabetes mellitus were included. The VEGF concentration in the aqueous humor was measured using an enzyme-linked immunosorbent assay.
RESULTS: The VEGF concentrations in the aqueous humor samples ranged from 25 to 241 pg/ml [mean ± standard deviation (SD), 116.6 ± 46.7 pg/ml]. The axial lengths ranged from 20.98 to 31.95 mm (mean ± SD, 24.09 ± 2.06 mm). The VEGF concentrations in the aqueous humor samples were correlated with axial length (Pearson product moment correlation test, ρ = -0.373; P = 0.003).
CONCLUSIONS: The concentration of VEGF in the aqueous humor is negatively correlated with axial length.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21607685     DOI: 10.1007/s10384-011-0027-1

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  29 in total

1.  Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relation.

Authors:  H G Blaauwgeers; G M Holtkamp; H Rutten; A N Witmer; P Koolwijk; T A Partanen; K Alitalo; M E Kroon; A Kijlstra; V W van Hinsbergh; R O Schlingemann
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

2.  Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema.

Authors:  Hideharu Funatsu; Hidetoshi Yamashita; Tomohiro Ikeda; Tatsuya Mimura; Shuichiro Eguchi; Sadao Hori
Journal:  Ophthalmology       Date:  2003-09       Impact factor: 12.079

3.  Ocular factors in the incidence and progression of diabetic retinopathy.

Authors:  S E Moss; R Klein; B E Klein
Journal:  Ophthalmology       Date:  1994-01       Impact factor: 12.079

4.  Prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion.

Authors:  Richard F Spaide; Louis K Chang; James M Klancnik; Lawrence A Yannuzzi; John Sorenson; Jason S Slakter; K Bailey Freund; Robert Klein
Journal:  Am J Ophthalmol       Date:  2008-10-17       Impact factor: 5.258

5.  Vitreous levels of stromal cell-derived factor 1 and vascular endothelial growth factor in patients with retinopathy of prematurity.

Authors:  Kenan Sonmez; Kimberly A Drenser; Antonio Capone; Michael T Trese
Journal:  Ophthalmology       Date:  2007-11-26       Impact factor: 12.079

6.  [Occurrence of changes in the eye in diabetic retinopathy with significant myopia].

Authors:  M Dujić; K Misailović; Lj Nikolić; M Ignjacev
Journal:  Srp Arh Celok Lek       Date:  1998 Nov-Dec       Impact factor: 0.207

7.  Intravitreal bevacizumab for choroidal neovascularization attributable to pathological myopia: one-year results.

Authors:  Yasushi Ikuno; Kaori Sayanagi; Kaori Soga; Miki Sawa; Motokazu Tsujikawa; Fumi Gomi; Yasuo Tano
Journal:  Am J Ophthalmol       Date:  2008-09-06       Impact factor: 5.258

8.  Changes in aqueous vascular endothelial growth factor and pigment epithelial-derived factor levels following intravitreal bevacizumab injections for choroidal neovascularization secondary to age-related macular degeneration or pathologic myopia.

Authors:  Wai-Man Chan; Timothy Y Y Lai; Kwok-Ping Chan; Haitao Li; David T L Liu; Dennis S C Lam; Chi-Pui Pang
Journal:  Retina       Date:  2008-10       Impact factor: 4.256

9.  Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion.

Authors:  Melvin D Rabena; Dante J Pieramici; Alessandro A Castellarin; Ma'an A Nasir; Robert L Avery
Journal:  Retina       Date:  2007 Apr-May       Impact factor: 4.256

10.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

Authors:  L P Aiello; R L Avery; P G Arrigg; B A Keyt; H D Jampel; S T Shah; L R Pasquale; H Thieme; M A Iwamoto; J E Park
Journal:  N Engl J Med       Date:  1994-12-01       Impact factor: 91.245

View more
  6 in total

1.  Retinal Microvascular Network and Microcirculation Assessments in High Myopia.

Authors:  Min Li; Ye Yang; Hong Jiang; Giovanni Gregori; Luiz Roisman; Fang Zheng; Bilian Ke; Dongyi Qu; Jianhua Wang
Journal:  Am J Ophthalmol       Date:  2016-11-04       Impact factor: 5.258

2.  Intracameral interleukin 1β, 6, 8, 10, 12p, tumor necrosis factor α and vascular endothelial growth factor and axial length in patients with cataract.

Authors:  Dan Zhu; Da-Yong Yang; Yuan-Yuan Guo; Yan-Fei Zheng; Jun-Lian Li; Bin Wang; Yong Tao; Jost B Jonas
Journal:  PLoS One       Date:  2015-02-13       Impact factor: 3.240

3.  Association between retinal microvasculature and optic disc alterations in high myopia.

Authors:  Jiangnan He; Qiuying Chen; Yao Yin; Hongfeng Zhou; Ying Fan; Jianfeng Zhu; Haidong Zou; Xun Xu
Journal:  Eye (Lond)       Date:  2019-04-24       Impact factor: 3.775

4.  Axial myopia, a protective factor for diabetic retinopathy-role of vascular endothelial growth factor.

Authors:  Ashish Kulshrestha; Nirbhai Singh; Bruttendu Moharana; Parul Chawla Gupta; Jagat Ram; Ramandeep Singh
Journal:  Sci Rep       Date:  2022-05-05       Impact factor: 4.996

5.  Alterations in the Choroidal Sublayers in Relationship to Severity and Progression of Diabetic Retinopathy: A Swept-Source OCT Study.

Authors:  Erica W T Kung; Victor T T Chan; Ziqi Tang; Dawei Yang; Zihan Sun; Yu Meng Wang; C H Chan; Michael C H Kwan; Jian Shi; Carol Y Cheung
Journal:  Ophthalmol Sci       Date:  2022-02-25

6.  Inflammatory cytokines in highly myopic eyes.

Authors:  Jianshu Yuan; Shanjun Wu; Yuewen Wang; Suqi Pan; Pengyun Wang; Lingyun Cheng
Journal:  Sci Rep       Date:  2019-03-05       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.